| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |